Royal Bank of Canada’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69K Sell
4,066
-303
-7% -$5.15K ﹤0.01% 5327
2025
Q4
$82K Sell
4,369
-20,515
-82% -$310K ﹤0.01% 5304
2025
Q3
$317K Buy
24,884
+9,336
+60% +$140K ﹤0.01% 4791
2025
Q2
$261K Buy
15,548
+11,237
+261% +$152K ﹤0.01% 4964
2025
Q1
$55K Sell
4,311
-61
-1% -$979 ﹤0.01% 5533
2024
Q4
$77K Sell
4,372
-1,679
-28% -$31.8K ﹤0.01% 5474
2024
Q3
$138K Sell
6,051
-26,726
-82% -$604K ﹤0.01% 5112
2024
Q2
$752K Sell
32,777
-390
-1% -$12K ﹤0.01% 3685
2024
Q1
$1.31M Sell
33,167
-2,985
-8% -$118K ﹤0.01% 3237
2023
Q4
$1.43M Buy
36,152
+2,624
+8% +$110K ﹤0.01% 3358
2023
Q3
$1.49M Buy
33,528
+1,276
+4% +$55.7K ﹤0.01% 3108
2023
Q2
$1.4M Sell
32,252
-268
-0.8% -$11.8K ﹤0.01% 3121
2023
Q1
$1.41M Sell
32,520
-6,434
-17% -$284K ﹤0.01% 3076
2022
Q4
$1.45M Sell
38,954
-9,016
-19% -$349K ﹤0.01% 3193
2022
Q3
$1.91M Sell
47,970
-18,481
-28% -$684K ﹤0.01% 2893
2022
Q2
$2.54M Sell
66,451
-9,544
-13% -$345K ﹤0.01% 2661
2022
Q1
$3.01M Sell
75,995
-2,666
-3% -$104K ﹤0.01% 2679
2021
Q4
$3.27M Buy
78,661
+1,970
+3% +$85.6K ﹤0.01% 2732
2021
Q3
$3.23M Sell
76,691
-78,009
-50% -$3.93M ﹤0.01% 2665
2021
Q2
$7.1M Sell
154,700
-90
-0.1% -$4.28K ﹤0.01% 2067
2021
Q1
$7.25M Sell
154,790
-9,667
-6% -$470K ﹤0.01% 1977
2020
Q4
$7.03M Buy
164,457
+140,276
+580% +$7.2M ﹤0.01% 1960
2020
Q3
$1.19M Buy
24,181
+662
+3% +$36.6K ﹤0.01% 3124
2020
Q2
$1.37M Buy
23,519
+1,344
+6% +$71K ﹤0.01% 2915
2020
Q1
$1.01M Buy
22,175
+262
+1% +$15.7K ﹤0.01% 3026
2019
Q4
$1.45M Buy
21,913
+4,587
+26% +$280K ﹤0.01% 3151
2019
Q3
$1M Buy
17,326
+2,275
+15% +$141K ﹤0.01% 3348
2019
Q2
$866K Buy
15,051
+1,749
+13% +$80.9K ﹤0.01% 3423
2019
Q1
$513K Buy
13,302
+918
+7% +$36K ﹤0.01% 3705
2018
Q4
$472K Buy
12,384
+1,414
+13% +$54.3K ﹤0.01% 3742
2018
Q3
$423K Buy
10,970
+4,601
+72% +$174K ﹤0.01% 4007
2018
Q2
$238K Buy
6,369
+41
+0.6% +$1.43K ﹤0.01% 4310
2018
Q1
$185K Buy
6,328
+850
+16% +$28.5K ﹤0.01% 4358
2017
Q4
$204K Buy
5,478
+304
+6% +$10.8K ﹤0.01% 4414
2017
Q3
$195K Buy
5,174
+1,780
+52% +$55.9K ﹤0.01% 4542
2017
Q2
$91K Sell
3,394
-159
-4% -$3.89K ﹤0.01% 4818
2017
Q1
$70K Buy
3,553
+533
+18% +$9.86K ﹤0.01% 4966
2016
Q4
$57K Buy
3,020
+1,076
+55% +$17.8K ﹤0.01% 5189
2016
Q3
$32K Buy
1,944
+505
+35% +$7.93K ﹤0.01% 5361
2016
Q2
$20K Sell
1,439
-1,461
-50% -$20.6K ﹤0.01% 5508
2016
Q1
$45K Buy
2,900
+651
+29% +$9.54K ﹤0.01% 5173
2015
Q4
$36K Buy
2,249
+1,544
+219% +$23.5K ﹤0.01% 5472
2015
Q3
$9K Sell
705
-281
-28% -$3.73K ﹤0.01% 5940
2015
Q2
$14K Buy
986
+879
+821% +$12.5K ﹤0.01% 5900
2015
Q1
$1K Sell
107
-101
-49% -$1.43K ﹤0.01% 5985
2014
Q4
$3K Buy
+208
New +$3.06K ﹤0.01% 5913
2013
Q4
Sell
-418
Closed -$8K 6069
2013
Q3
$8K Buy
+418
New +$7.18K ﹤0.01% 5491

Other funds holding NRC

Royal Bank of Canada's NRC Position: Q1 2026 in Review

Royal Bank of Canada reduced its NRC Health Common Stock (NRC) stake by 6.9% in Q1 2026, selling an estimated $5.15K and leaving 4,066 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #5327.

Royal Bank of Canada first reported a position in NRC in Q3 2013 and has held it in 47 quarters since. The position peaked at $7.25M in Q1 2021. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Royal Bank of Canada held 4,066 shares of NRC Health Common Stock worth $69K as of Q1 2026.
  • Royal Bank of Canada sold 303 NRC Health Common Stock shares in Q1 2026, an estimated $5.15K.
  • NRC Health Common Stock made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5327 holding.
  • Royal Bank of Canada first reported a position in NRC Health Common Stock in Q3 2013 and has held it in 47 quarters since.
  • Royal Bank of Canada's NRC Health Common Stock position peaked at $7.25M in Q1 2021.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.